Page results
-
The COVID Medicines Delivery Unit (CMDU gives new COVID-19 treatments for patients at highest risk in the community from the NCL sector. These treatments involve intravenous infustion of neutralising monoclonal antibodies (nMABs) or oral antiviral treatments, which are given to high-risk patients who have had a positive PCR test.
-
This page has been written to explain how to keep your wound clean after head and neck surgery.
-
This page provides information about endovascular treatment of Subdural Hematomas (SDH).
-
The aim of this page is to provide you with information about flow-diverting stents and how they are used to treat cerebral (brain) aneurysms.
-
UCLH has recruited the first participant in Europe to a global clinical trial for adults with Myotonic Dystrophy Type 1 (DM1)- a genetic condition and type of muscular dystrophy that causes progressive muscle weakness and wasting.
-
At UCLH we use many different drugs to treat patients with cancer. Chemotherapy is the treatment of cancer with drugs designed to control or destroy the growth of the tumour.
-
Dr Maria Michelagnoli is a paediatric oncologist with a special interest in bone tumours, rhabdomyosarcoma, fibromatosis and bone presentations of LCH
-
We are now administering new COVID-19 treatments for patients at highest risk in the community. The service can prescribe oral antivirals to be taken at home, and give intravenous antibody treatments at the hospital.
-
This is a speech and language therapy service for deaf or hard of hearing adults who are having communication difficulties because of a hearing loss. The primary focus of the service is to help with spoken English skills.
-
How we use your information at UCLH: what you need to know.
